Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care
View More
Go To PER in Chicago
May 30, 2025 - June 3, 2025
Register Now!
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care
View More
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes
View More
Does Adjuvant Radiation Make Sense for Older Patients With Triple-Negative Breast Cancer?
October 2nd 2015Little is known about the potential benefits of adjuvant radiotherapy in older women diagnosed with triple-negative breast cancer (TNBC), but findings of a retrospective study reported at the 2015 Breast Cancer Symposium suggest that the approach may be worth considering for this population.
Hormones May Protect Ovaries, Preserve Fertility in Breast Cancer
September 29th 2015Chemotherapy in young women can damage ovaries and result in premature menopause, but new research shows that the addition of hormonal treatment may preserve ovarian function and fertility in patients with breast cancer and may increase the chances of pregnancy after treatment.
Diet With Extra Olive Oil May Lower Risk of Breast Cancer
September 17th 2015A study to test the effects of the Mediterranean diet on the prevention of cardiovascular disease yielded an unexpected result-the Mediterranean diet supplemented with extra virgin olive oil (EVOO) lowered the risk of breast cancer in older women by 68%.
Acupuncture Abates Hot Flashes in Breast Cancer Survivors
September 14th 2015Hot flashes are severe, daily nuisances for many breast cancer survivors, but a few needle pricks from acupuncture may be enough to cool the unpleasant episodes, according to a new study published in the Journal of Clinical Oncology.
Women in Appalachia Need Support to Optimize Their Adjuvant Breast Cancer Therapy
July 28th 2015A new study has uncovered notable disparities in uptake of adjuvant breast cancer therapies in the Appalachian region of the United States, suggesting targeted intervention strategies may help to improve outcomes for this population of women.
More Sensitive Stress-Management Tools Needed for Latina Women With Breast Cancer
June 26th 2015A study looking at the care experiences and possible stressors for Latina women undergoing chemotherapy to treat their breast cancer has found that this patient population feels particular stress related to their family and other interpersonal relationships.
More Women Are Choosing Breast-Conserving Surgery, but Disparities Remain
June 17th 2015The number of women deciding to have breast-conserving therapy to treat their early-stage breast cancer has been steadily increasing, but these gains are muted for some women due to such factors as insurance status, income, and travel distance to treatment centers.
Novel Oral Agent Palbociclib Stalls Progression in HR-Positive Breast Cancer
May 31st 2015Adding palbociclib (Ibrance) to standard fulvestrant more than doubled progression-free survival in pretreated patients with HR-positive, HER2-negative breast cancer, according to study results presented at the 2015 ASCO Annual Meeting.
For Survivors of Breast Cancer, Weight Training Helps Fend Off Physical Decline
May 26th 2015Weight training was shown to help stave off deterioration of physical function in breast cancer survivors, conferring a benefit twice that of women in a control group who did not participate in the weight-lifting intervention.